Acute Stress Reaction
12
6
6
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Breathwork and Stress: Investigating the Mechanisms of Action and Effectiveness of Breathing Interventions in Modulating the Psychophysiological Response to Acute Stress Test
BXCL501 After Stress to Increase Recovery Success
Impact of MetaCalm on Stress of Healthy People With Acute Stress
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
Promoting Improved Functioning Among People Experiencing Stressful Situations
Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction
Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes
Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands
The Effect of Breathing on Cognitive Performance and Stress
Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects
Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects